Guofeng F. Chen

Beijing, 100039, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Prediction of biochemical nonresolution in patients with chronic drug-induced liver injury: A large multicenter study.

Prediction of biochemical nonresolution in patients with chronic drug-induced liver injury: A large multicenter study.

Journal: Hepatology (Baltimore, Md.)

Published: February 10, 2021

Sustained serological and complete responses in HBeAg-positive patients treated with Peginterferon alfa-2b: a 6-year long-term follow-up of a multicenter, randomized, controlled trial in China.

Sustained serological and complete responses in HBeAg-positive patients treated with Peginterferon alfa-2b: a 6-year long-term follow-up of a multicenter, randomized, controlled trial in China.

Journal: BMC gastroenterology

Published: January 23, 2018

Qualitative pathological assessment of liver fibrosis regression after antiviral therapy in patients with chronic hepatitis B

Qualitative pathological assessment of liver fibrosis regression after antiviral therapy in patients with chronic hepatitis B

Journal: Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology

Published: January 12, 2018

Reply.

Reply.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: December 12, 2016

Efficacy and safety of 3-week response-guided triple direct-acting antiviral therapy for chronic hepatitis C infection: a phase 2, open-label, proof-of-concept study.

Efficacy and safety of 3-week response-guided triple direct-acting antiviral therapy for chronic hepatitis C infection: a phase 2, open-label, proof-of-concept study.

Journal: The lancet. Gastroenterology & hepatology

Published: December 06, 2016

Hepatitis B reactivation in hepatitis B and C coinfected patients treated with antiviral agents: A systematic review and meta-analysis.

Hepatitis B reactivation in hepatitis B and C coinfected patients treated with antiviral agents: A systematic review and meta-analysis.

Journal: Hepatology (Baltimore, Md.)

Published: September 28, 2016

New classification of liver biopsy assessment for fibrosis in chronic hepatitis B patients before and after treatment.

New classification of liver biopsy assessment for fibrosis in chronic hepatitis B patients before and after treatment.

Journal: Hepatology (Baltimore, Md.)

Published: August 17, 2016

HBsAg and HBeAg in the prediction of a clinical response to peginterferon α-2b therapy in Chinese HBeAg-positive patients.

HBsAg and HBeAg in the prediction of a clinical response to peginterferon α-2b therapy in Chinese HBeAg-positive patients.

Journal: Virology journal

Published: April 14, 2016

Hepatitis due to Reactivation of Hepatitis B Virus in Endemic Areas Among Patients With Hepatitis C Treated With Direct-acting Antiviral Agents.

Hepatitis due to Reactivation of Hepatitis B Virus in Endemic Areas Among Patients With Hepatitis C Treated With Direct-acting Antiviral Agents.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: March 31, 2016

The efficacy and prognostic predictors of different treatment courses with pegylated interferon α-2a and ribavirin combination in recurrent chronic hepatitis C patients

The efficacy and prognostic predictors of different treatment courses with pegylated interferon α-2a and ribavirin combination in recurrent chronic hepatitis C patients

Journal: Zhonghua nei ke za zhi

Published: December 18, 2015

Improvement of glucose and lipid metabolism with pegylated interferon-a plus ribavirin therapy in Chinese patients chronically infected with genotype 1b hepatitis C virus.

Improvement of glucose and lipid metabolism with pegylated interferon-a plus ribavirin therapy in Chinese patients chronically infected with genotype 1b hepatitis C virus.

Journal: Annals of Saudi medicine

Published: October 27, 2015

High sustained virological response to optimized therapy for refractory chronic hepatitis C treatment-na(i)ve patients: a multicenter randomized study

High sustained virological response to optimized therapy for refractory chronic hepatitis C treatment-na(i)ve patients: a multicenter randomized study

Journal: Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology

Published: August 04, 2015

Showing 1-12 of 15

Last Updated: 09/26/2026